Cellular Dynamics International is the world’s largest producer of fully functional human cells derived from induced pluripotent stem (iPS) cells. Our iCell™ product lines provide industrialized quantities of pure, homogenous, terminally differentiated human cells enabling basic research, efficient drug discovery programs, and reliably predictive toxicity and efficacy screening through in vitro clinical trials.
Our iCell Cardiomyocytes improve the predictability of your drug compound efficacy and toxicity screens and more accurately predict human in vivo response. Hepatocytes, neurons, and endothelial cells are also in active development and testing for release in 2011.